A Novel Probability Model for LncRNA–Disease Association Prediction Based on the Naïve Bayesian Classifier

An increasing number of studies have indicated that long-non-coding RNAs (lncRNAs) play crucial roles in biological processes, complex disease diagnoses, prognoses, and treatments. However, experimentally validated associations between lncRNAs and diseases are still very limited. Recently, computational models have been developed to discover potential associations between lncRNAs and diseases by integrating multiple heterogeneous biological data; this has become a hot topic in biological research. In this article, we constructed a global tripartite network by integrating a variety of biological information including miRNA–disease, miRNA–lncRNA, and lncRNA–disease associations and interactions. Then, we constructed a global quadruple network by appending gene–lncRNA interaction, gene–disease association, and gene–miRNA interaction networks to the global tripartite network. Subsequently, based on these two global networks, a novel approach was proposed based on the naïve Bayesian classifier to predict potential lncRNA–disease associations (NBCLDA). Comparing with the state-of-the-art methods, our new method does not entirely rely on known lncRNA–disease associations, and can achieve a reliable performance with effective area under ROC curve (AUCs)in leave-one-out cross validation. Moreover, in order to further estimate the performance of NBCLDA, case studies of colorectal cancer, prostate cancer, and glioma were implemented in this paper, and the simulation results demonstrated that NBCLDA can be an excellent tool for biomedical research in the future.

[1]  Franklin G. Berger Interview: Screening and treatment for colorectal cancer , 2013 .

[2]  Xiangxiang Zeng,et al.  Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks , 2016, Briefings Bioinform..

[3]  MA ZHIPENG,et al.  SNHG 5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p 27 , .

[4]  H. Cao,et al.  LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675. , 2016, European review for medical and pharmacological sciences.

[5]  Peng Huang,et al.  Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer , 2017, Cell Death & Disease.

[6]  Xia Li,et al.  Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer , 2015, Nucleic acids research.

[7]  J. Mattick,et al.  Non‐coding RNAs: regulators of disease , 2010, The Journal of pathology.

[8]  Xabier Agirre,et al.  Long Non-Coding RNAs in Haematological Malignancies , 2013, International journal of molecular sciences.

[9]  I. Bièche,et al.  ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Jingpu Zhang,et al.  Integrating Multiple Heterogeneous Networks for Novel LncRNA-Disease Association Inference , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[11]  Christoph Plass,et al.  Role of lncRNAs in prostate cancer development and progression , 2014, Biological chemistry.

[12]  Zhen Liu,et al.  Link prediction in complex networks: A local naïve Bayes model , 2011, ArXiv.

[13]  Jiancheng Luo,et al.  Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications , 2014, Scientific Reports.

[14]  Wei Kong,et al.  A bioinformatics method for predicting long noncoding RNAs associated with vascular disease , 2014, Science China Life Sciences.

[15]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[16]  Bo Liao,et al.  Global network random walk for predicting potential human lncRNA-disease associations , 2017, Scientific Reports.

[17]  Jiayi Wang,et al.  CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer , 2010, Nucleic acids research.

[18]  Nataša Pržulj,et al.  Methods for biological data integration: perspectives and challenges , 2015, Journal of The Royal Society Interface.

[19]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[20]  Hui Zhao,et al.  Long non-coding RNA NEAT1 contributes to docetaxel resistance of prostate cancer through inducing RET expression by sponging miR-34a , 2017 .

[21]  J. Hou,et al.  Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. , 2013, The Journal of urology.

[22]  T. Morgan,et al.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase , 2008, Nature Medicine.

[23]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[24]  Kazuhiro Murakami,et al.  Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers , 2006, Cancer science.

[25]  Ao Li,et al.  TPGLDA: Novel prediction of associations between lncRNAs and diseases via lncRNA-disease-gene tripartite graph , 2018, Scientific Reports.

[26]  Zhipeng Ma,et al.  lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27. , 2017, Oncology letters.

[27]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[28]  Chuanliang Xu,et al.  The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. , 2013, Urologic oncology.

[29]  Jing Quan,et al.  lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis. , 2018, Gene.

[30]  Yi Pan,et al.  Prediction of lncRNA–disease associations based on inductive matrix completion , 2018, Bioinform..

[31]  Eugenia G. Giannopoulou,et al.  The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer , 2014, Nature Communications.

[32]  Lei Wang,et al.  A Novel Method for LncRNA-Disease Association Prediction Based on an lncRNA-Disease Association Network , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[33]  S. Lottin,et al.  The human H19 gene is frequently overexpressed in myometrium and stroma during pathological endometrial proliferative events. , 2005, European journal of cancer.

[34]  Yue Zhao,et al.  MNDR v2.0: an updated resource of ncRNA–disease associations in mammals , 2017, Nucleic Acids Res..

[35]  G. Su,et al.  Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma , 2015, Tumor Biology.

[36]  D. Spector,et al.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. , 2013, Cancer research.

[37]  Lin Liu,et al.  Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. , 2014, Molecular bioSystems.

[38]  Xing Chen KATZLDA: KATZ measure for the lncRNA-disease association prediction , 2015, Scientific Reports.

[39]  Guodong Yang,et al.  LncRNA: a link between RNA and cancer. , 2014, Biochimica et biophysica acta.

[40]  J. Mattick,et al.  Long noncoding RNAs and the genetics of cancer , 2013, British Journal of Cancer.

[41]  Massoud Saidijam,et al.  A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy , 2016, Tumor Biology.

[42]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[43]  A. Chinnaiyan,et al.  The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.

[44]  Martin Klein,et al.  Psychiatric symptoms in glioma patients: from diagnosis to management , 2015, Neuropsychiatric disease and treatment.

[45]  Xu Gao,et al.  Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3 , 2016, Oncotarget.

[46]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[47]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[48]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[49]  Meng Zhang,et al.  LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis , 2016, Experimental biology and medicine.

[50]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[51]  Qin Chen,et al.  lncRNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI , 2014, The FEBS journal.

[52]  Lei Wang,et al.  Prediction of microRNA-disease associations based on distance correlation set , 2018, BMC Bioinformatics.

[53]  K. Jeang,et al.  NEAT1 Long Noncoding RNA and Paraspeckle Bodies Modulate HIV-1 Posttranscriptional Expression , 2013, mBio.

[54]  Xing Chen,et al.  Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA , 2015, Scientific Reports.

[55]  L. Du,et al.  MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2 , 2017, Molecular Cancer Therapeutics.

[56]  Xinghua Shi,et al.  A Network Based Method for Analysis of lncRNA-Disease Associations and Prediction of lncRNAs Implicated in Diseases , 2014, PloS one.

[57]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[58]  J. Rinn,et al.  Modular regulatory principles of large non-coding RNAs , 2012, Nature.

[59]  R. Spizzo,et al.  Long non-coding RNAs and cancer: a new frontier of translational research? , 2012, Oncogene.

[60]  Xu Feng,et al.  Insights into the roles of lncRNAs in skeletal and dental diseases , 2018, Cell & Bioscience.

[61]  Guangyuan Fu,et al.  Matrix factorization-based data fusion for the prediction of lncRNA–disease associations , 2018, Bioinform..

[62]  Xiangxiang Zeng,et al.  Probability-based collaborative filtering model for predicting gene–disease associations , 2017, BMC Medical Genomics.

[63]  Nicholas T. Ingolia,et al.  Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins , 2013, Cell.

[64]  Cheng Liang,et al.  Collective Prediction of Disease-Associated miRNAs Based on Transduction Learning , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[65]  Xing Chen,et al.  A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs , 2014, PloS one.